Skip to main content

How Biosimilar Manufacturers Can Get the Most Out of the "Patent Cliff"

MAY 2020
Share the article

Pharmaceutical Executive is a US-based trade magazine that provides strategic, business management content for senior executives, corporate strategists, and sales & marketing leaders in the global pharmaceutical industry.

With biosimilars becoming increasingly popular, it is vital for manufacturers to make the most of every chance to set their products apart and build trust with potential buyers. In this article, George I’ons, Head of Product Strategy at Owen Mumford Pharmaceutical Services, reviews the five essential requirements for a successful biosimilar launch.

Get in touch

* Field is required.